MPG.eBooks - Search Results - "Infection"

Cover Image

1

CADTH Canadian Drug Expert Committee recommendation: Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamide (Symtuza -- Janssen Inc.) : indication: treatment of HIV type 1 (HIV-1...

Published 2018

Canadian Agency for Drugs and Technologies in Health

Subjects: “...HIV Infections / drug therapy...”

Cover Image

2

CADTH Canadian drug expert committee recommendation: Doravirine/Lamivudine/Tenofovir disoproxil fumarate (Delstrigo -- Merck Canada Inc.) : indication: as a complete regimen for th...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...HIV Infections / drug therapy...”

Cover Image

3

CDEC final recommendation: Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection

Published 2014

Canadian Agency for Drugs and Technologies in Health

Subjects: “...HIV Infections / drug therapy...”

Cover Image

4

CDEC final recommendation: Dolutegravir (Tivicay -- ViiV Healthcare ULC) : indication : HIV infection

Published 2014

Canadian Agency for Drugs and Technologies in Health

Subjects: “...HIV Infections / drug therapy...”

Cover Image

5

CADTH Canadian Drug Expert Committee final recommendation: Emtricitabine / tenofovir alafenamide (Descovy -- Gilead Sciences Canada, Inc.) indication : HIV-1 infection

Published 2016

Canadian Agency for Drugs and Technologies in Health

Subjects: “...HIV Infections / drug therapy...”

Cover Image

6

CADTH Canadian drug expert committee recommendation: Doravirine (Pifeltro -- Merck Canada Inc.) : indication: in combination with other antiretroviral medicinal products, for the t...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...HIV Infections / drug therapy...”

Cover Image

7

CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Lamivudine (Dovato -- ViiV healthcare ULC) : indication: as a complete regimen for the treatment of human immunode...

Published 2019

CADTH

Subjects: “...HIV Infections / drug therapy...”

Cover Image

8

CADTH Canadian drug expert committee recommendation: Doravirine (Pifeltro -- Merck Canada Inc.) : indication: in combination with other antiretroviral medicinal products, for the t...

Published 2019

Canadian Agency for Drugs and Technologies in Health

Subjects: “...HIV Infections / drug therapy...”

Cover Image

9

CADTH Canadian Drug Expert Committee recommendation (final): Letermovir (Prevymis -- Merck Canada Inc.) indication : cytomegalovirus infection, prophylaxis

Published 2018

CADTH

Subjects: “...Cytomegalovirus Infections / drug therapy...”

Cover Image

10

CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...

Published 2018

CADTH

Subjects: “...HIV Infections / drug therapy...”

Cover Image

11

CADTH Canadian Drug Expert Committee recommendation: Dolutegravir/Rilpivirine (Juluca -- ViiV healthcare) : indication : the treatment of human immunodeficiency virus (HIV-1) infec...

Published 2018

CADTH

Subjects: “...HIV Infections / drug therapy...”